References
- . Calderón EJ, Gutiérrez-Rivero S, Durand-Joly I, Dei-Cas E. Pneumocystis infection in humans: diagnosis and treatment. Expert Rev Anti Infect Ther. 2010;8(6):683–701
- . Morris A, Lundgren JD, Masur H, . Current epidemiology of Pneumocystis Pneumonia. Emerg Infect Dis. 2004;10(10):1713–1720
- . Calderón EJ. Pneumocystis infection: seeing beyond the tip of the iceberg. Clin Infect Dis. 2010;50(3):354–356
- . Calderón EJ. Epidemiology of Pneumocystis infection in human. J Mycol Med. 2009;19:270–275
- . Morris A, Wei K, Afshar K, Huang L. Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis. 2008;197(1):10–17
- . Huang L, Crothers K, Atzori C, . Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance. Emerg Infect Dis. 2004;10(10):1721–1728
- . Stein C, Poole C, Kazanjian P, Meshnick SR. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia. Emerg Infect Dis. 2004;10(10):1760–1765
- . Calderon EJ, de la Horra C, Montes-Cano MA, . Resistencia genotípica a sulfamidas en pacientes con neumonía por Pneumocystis jiroveci. Med Clin. 2004;122(16):617–619
- . Calderon E, de la Horra C, Medrano FJ, . Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis. Eur J Clin Microbiol Infect Dis. 2004;23(7):545–549
- . Huang L, Beard CB, Creasman J, . Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. J Infect Dis. 2000;182(4):1192–1198
- . Montes-Cano MA, de la Horra C, Martín-Juan J, . Pneumocystis jiroveci genotypes in the Spanish population. Clin Infect Dis. 2004;39(1):123–128
- . Totet A, Latouche S, Lacube P, . Pneumocystis jirovecii dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France. Emerg Infect Dis. 2004;10(10):667–673
- . Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, Lundgren B. Effects of mutations in dihydropteroate synthase gene on outcome of AIDS associated P. carinii pneumonia. Lancet. 1999;354(9187):1347–1351
- . Visconti E, Ortona E, Mencarini P, . Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia. Int J Antimicrob Agents. 2001;18(6):547–551
- . Costa MC, Helweg-Larsen J, Lundgren B, Antunes F, Matos O. Mutations in the dihydropteroate synthase gene of Pneumocystis jirovecii isolates from Portuguese patients with Pneumocystis pneumonia. Int J Antimicrob Agents. 2003;22(5):510–520
- . Esteves F, Montes-Cano MA, de la Horra C, . Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin Microbiol Infect. 2008;14(4):356–362
- . Alvarez-Martínez MJ, Moreno A, Miró JM, . Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality. Diagn Microbiol Infect Dis. 2008;62(1):34–43
- . Kazanjian P, Locke AB, Hossler PA, . Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients. AIDS. 1998;12(8):873–878
- . Armstrong W, Meshnick S, Kazanjian P. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients. Microbes Infect. 2000;2(1):61–67
- . Nahimana A, Rabodonirina M, Bille J, Francioli P, Hauser PM. Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. Antimicrob Agents Chemother. 2004;48(11):4301–4305
- . Chabe M, Dei-Cas E, Creusy C, . Immunocompetent hosts as a reservoir of Pneumocystis organisms: histological and rt-PCR data demonstrate active replication. Eur J Clin Microbiol Infect Dis. 2004;23(2):89–97
- . Rivero L, de la Horra C, Montes-Cano MA, . Pneumocystis jirovecii transmission from immunocompetent carriers to infant. Emerg Infect Dis. 2008;14(7):1116–1118
- . Nevez G, Chabé M, Rabodonirina M, . Nosocomial Pneumocystis jirovecii infections. Parasite. 2008;15(3):359–365